Get started
Author

Tomoyasu Yoshihiro

PD ‐1+ TIM ‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
2018 · Michitaka Nakano, Mamoru Ito, et al. · Cancer Science · 44
PDF
Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report
2017 · Tomoyasu Yoshihiro, Kenta Nio, et al. · Molecular and Clinical Oncology · 24
PDF
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer
2019 · Tomoyasu Yoshihiro, Hitoshi Kusaba, et al. · International Journal of Clinical Oncology · 19
Successful chemotherapeutic treatment for metastatic littoral cell angioma
2018 · Kotoe Takayoshi, Goro Doi, et al. · Medicine · 18
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans
2017 · Kenji Tsuchihashi, Hitoshi Kusaba, et al. · Molecular and Clinical Oncology · 14
PDF
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
2020 · Kenji Tsuchihashi, Hitoshi Kusaba, et al. · Scientific Reports · 12
PDF
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model
2022 · Kyoko Yamaguchi, Tomoyasu Yoshihiro, et al. · Gastric Cancer · 11
PDF
Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules
2017 · Tsuyoshi Muta, Tomoyasu Yoshihiro, et al. · Internal Medicine · 9
PDF
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer
2024 · Kyoko Yamaguchi, Mamoru Ito, et al. · JCO Precision Oncology · 8
Inhibition of insulin‐like growth factor‐1 receptor enhances eribulin‐induced DNA damage in colorectal cancer
2022 · Tomoyasu Yoshihiro, Hiroshi Ariyama, et al. · Cancer Science · 7
Lingual alveolar soft part sarcoma responsive to pazopanib
2017 · Tomoyasu Yoshihiro, Kenji Tsuchihashi, et al. · Medicine · 6
Cardiac metastasis of squamous cell carcinoma of the thyroid gland with severe disseminated intravascular coagulation: A case report
2016 · Tomoyasu Yoshihiro, Kenji Tsuchihashi, et al. · Molecular and Clinical Oncology · 6
PDF
Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis
2025 · Tomoyasu Yoshihiro, Kyoko Yamaguchi, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 4
Nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable or recurrent pancreatic cancer: a multicenter observational study (NAPOLEON-2)
2025 · T. Shirakawa, M. Shimokawa, et al. · ESMO Gastrointestinal Oncology · 4
PDF
Efficacy and adverse events of azacitidine in the treatment of hemodialysis patients with high-risk myelodysplastic syndrome.
2016 · Tomoyasu Yoshihiro, Tsuyoshi Muta, et al. · PubMed · 4
Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer
2020 · Ryosuke Taguchi, Kenji Tsuchihashi, et al. · Internal Medicine · 3
PDF
Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex
2017 · Kenji Tsuchihashi, Tomoyasu Yoshihiro, et al. · Medicine · 3
Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report
2025 · Takafumi Kitazono, Taichi Isobe, et al. · International Cancer Conference Journal · 2
Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma
2018 · Kenji Tsuchihashi, Shuji Arita, et al. · Medicine · 2
388P Impact of prior treatments on the efficacy of nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable or recurrent pancreatic cancer (NAPOLEON-2 study)
2025 · T. Yoshihiro, A. Takigawa, et al. · Annals of Oncology
Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study
2025 · Tomomi Koike, Yasunori Kawaguchi, et al. · Therapeutic Advances in Medical Oncology
インスリン様成長因子1受容体阻害は大腸癌においてエリブリンによるdna損傷を増強する
2025 · YOSHIHIRO, Tomoyasu · Institutional Repositories DataBase (IRDB)
PDF
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan
2023 · Kenji Tsuchihashi, Mamoru Ito, et al. · BMC Cancer
PDF
Adult head and neck para-meningeal rhabdomyosarcoma: survival outcomes including salvage therapy
2023 · Kenji Tsuchihashi, Mamoru Ito, et al. · Research Square
PDF
Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib
2020 · Kenta Nio, Kenji Tsuchihashi, et al. · International Journal of Surgery Oncology
Works count: 26
Citation count: 199
H-index: 8
I10-index: 7
Year
Topic
Type